Seeing Is Believing
SLDB is currently covered by 4 analysts with an average potential upside of $13.04 (18.94%) from yesterday's end of day stock price of $5.06. Solid Biosciences activity chart has currently 14 price targets and 36 ratings on display.
Analysts average stock forecasts to be materialized ratio is 69.5% with an average time for these price targets to be met of 106.1 days.
Highest price target for SLDB is $15, Lowest price target is $7, average price target is $11.
Most recent stock forecast was given by GENA WANG from BARCLAYS on 11-Nov-2022. First documented stock forecast 20-Feb-2018.
Currently, out of the existing stock ratings of SLDB - 5 which are a Hold (71.43%), 2 which are a Buy (28.57%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$5.9 (280.95%)
120
1 years 29 days ago
0/3 (0%)
$34.71 (56.34%)
Hold
1 years 1 months 23 days ago
2/2 (100%)
$12.15 (11.27%)
17
Hold
135
1 years 2 months 10 days ago
2/2 (100%)
$-4.8 (-3.43%)
4
Buy
6
$-0.96 (-13.79%)
7
1 years 3 months 28 days ago
4/4 (100%)
$-12.32 (-45.04%)
97
Hold
1 years 6 months 21 days ago
0/1 (0%)
$41.1 (84.05%)
What is SLDB (Solid Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on SLDB (Solid Biosciences) with a proven track record?
Which analyst has the most public recommendations on SLDB (Solid Biosciences)?
Which analyst is the currently most bullish on SLDB (Solid Biosciences)?
Which analyst is the currently most reserved on SLDB (Solid Biosciences)?